A clinical-stage oncology compound selectively targets drug-resistant cancers
一种处于临床阶段的肿瘤化合物可选择性地靶向耐药性癌症。
期刊:
影响因子:
doi:10.1101/2025.11.26.690878
Long, Kaitlin; Bhattacharjee, Debanjan; Newman-Stonebraker, Samuel H; Suhr, Simon; Mercado, Brandon Q; Scheib, Emily; Tighe, Anthony; Romero, Luciano; Thompson, Sarah L; Sausville, Erin L; John, Kristen M; Julian, Linda; Mishra, Sanat; Klingbeil, Olaf; Gupta, Punya; Bhatt, Uditi; Gao, Allen C; Ricardo, Sara; Vakoc, Christopher R; Bornhauser, Beat C; Corsello, Steven M; Taylor, Stephen S; Chen, Jue; Holland, Patrick L; Sheltzer, Jason M